UnitedHealth Beats Expectations, Boosts Profit Forecast

UnitedHealth announced it has surpassed first-quarter performance expectations, leading to an upward revision of its annual profit forecast. The company attributed its success to effective cost management and improved government reimbursements for its health insurance offerings. This financial strength was reflected in a 7% rise in UnitedHealth's stock price in premarket trading, with industry peers also seeing gains.

The company's financial chief highlighted a focus on maintaining a prudent 2026 outlook, emphasizing execution as a key driver of results. UnitedHealth reported a first-quarter medical cost ratio of 83.9%, lower than anticipated, despite expecting to lose 1.3 million Medicaid members. The company now projects its 2026 adjusted profit per share to exceed $18.25, an increase of 50 cents from its previous forecast.

Significant corporate activities during the quarter included the agreement to acquire Alegeus Technologies and the divestiture of its Optum UK business. UnitedHealth also committed to a stock buyback program of at least $2 billion by the end of the second quarter. Despite a 15% dip in operating income at its Optum health services unit, attributed to higher medical costs and strategic enrollment adjustments, overall revenue for Optum Health reached $24.1 billion, while Optum Rx saw a 2% revenue increase.